Sort
23,748 grants matching “melanoma”
Targeting Fyn and RSK2 Pathways for Chemoprevention of Solar UV-lnduced Skin Can
$167,238Zigang Dong · University Of Arizona · P01 · FY2011 · CA
A prognostic mRNA immune signature for resected stage II-III melanoma
$167,236Yvonne Margaret Saenger · Columbia University Health Sciences · UH2 · FY2020 · CA
Targeting T Cell Senescence and Dysfunction for Anti-tumor Immunity
$167,231Guangyong Peng · Saint Louis University · R01 · FY2021 · CA
Gene Discovery in Melanoma Etiology
$167,224Wistar Institute · P50 · FY2005 · CA
Gene Discovery in Melanoma Etiology
$167,224Wistar Institute · P50 · FY2004 · CA
Targeted antigen delivery for cancer immunotherapy
$167,200Shoshana Frankenburg · Hadassah-Hebrew University Medical Ctr · R21 · FY2006 · CA
CORE--NUDE/SCID MOUSE FACILITY
$167,178University Of California Los Angeles · P30 · FY2002 · CA
CORE--NUDE/SCID MOUSE FACILITY
$167,178University Of California Los Angeles · P30 · FY2001 · CA
Modulating cancer progression by adipogenic human adenovirus type 36
$167,170Lei Cao · Ohio State University · R21 · FY2014 · CA
Targeting Smad3-Ski for Therapeutic Development in Pancreatic Cancer
$167,063F. Michael Hoffmann · University Of Wisconsin-Madison · R21 · FY2008 · CA
Common hTERT Promoter Mutations Represent a Novel Therapeutic Target
$167,023Donald M Miller · University Of Louisville · R21 · FY2016 · CA
Endogenous MHC class II antigen processing via autophagy
$167,019Christian Munz · University Of Zurich · R01 · FY2008 · CA
Tumor downstaging with small molecule therapeutics to enhance Uveal Melanoma metastasis eradication by B7-H3 CAR T cells
$167,000Cristina R. Ferrone · Cedars-Sinai Medical Center · R03 · FY2023 · CA
PVSRIPO in melanoma
$166,997Georgia Beasley · Duke University · K08 · FY2021 · CA
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
$166,958Niroshana Anandasabapathy · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · AR
NKT cells with chimeric antigen receptors
$166,931Tonya J. Webb · University Of Maryland Baltimore · R21 · FY2015 · CA
A novel IL-2 biologic and tumor immunity
$166,931Thomas R Malek · University Of Miami School Of Medicine · R21 · FY2016 · CA
Developing novel strategies for altering the cytokine microenvironment of tumors
$166,931John G. Frelinger · University Of Rochester · R21 · FY2015 · CA
Epigenetic reprogramming of melanoma cells by vitamin C treatment
$166,931Gaofeng Wang · University Of Miami School Of Medicine · R21 · FY2016 · CA
Role of E2F1 in eugenol-mediated antiproliferative activity in melanoma cells
$166,922Rita Ghosh · University Of Texas Hlth Science Center · R21 · FY2009 · CA
Multiple Antigen-Engineered DC Immunication & IFNa Boost for Metastatic Melanoma
$166,842Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P50 · FY2011 · CA
MOLECULAR GENETICS OF PRIMARY UVEAL MELANOMA
$166,804Johns Hopkins University · K08 · FY2000 · EY
Assessing Resident Physician Melanoma Detection Across Ethnic Groups
$166,721Claudia Hernandez · University Of Illinois At Chicago · R21 · FY2014 · CA
Cancer and Leukemia Group B
$166,705Jeffrey None Crawford · Duke University · U10 · FY2008 · CA
In Vivo Pharmacodynamics of RNAi-based Cancer Therapies
$166,623Mark E Davis · California Institute Of Technology · U54 · FY2014 · CA